Current applications of deep-learning in neuro-oncological MRI.

(max 4): Magnetic Resonance Imaging Artificial Intelligence Deep Learning Neuro-Oncology

Journal

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
ISSN: 1724-191X
Titre abrégé: Phys Med
Pays: Italy
ID NLM: 9302888

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 26 11 2020
revised: 01 02 2021
accepted: 02 03 2021
pubmed: 30 3 2021
medline: 25 6 2021
entrez: 29 3 2021
Statut: ppublish

Résumé

Magnetic Resonance Imaging (MRI) provides an essential contribution in the screening, detection, diagnosis, staging, treatment and follow-up in patients with a neurological neoplasm. Deep learning (DL), a subdomain of artificial intelligence has the potential to enhance the characterization, processing and interpretation of MRI images. The aim of this review paper is to give an overview of the current state-of-art usage of DL in MRI for neuro-oncology. We reviewed the Pubmed database by applying a specific search strategy including the combination of MRI, DL, neuro-oncology and its corresponding search terminologies, by focussing on Medical Subject Headings (Mesh) or title/abstract appearance. The original research papers were classified based on its application, into three categories: technological innovation, diagnosis and follow-up. Forty-one publications were eligible for review, all were published after the year 2016. The majority (N = 22) was assigned to technological innovation, twelve had a focus on diagnosis and seven were related to patient follow-up. Applications ranged from improving the acquisition, synthetic CT generation, auto-segmentation, tumor classification, outcome prediction and response assessment. The majority of publications made use of standard (T1w, cT1w, T2w and FLAIR imaging), with only a few exceptions using more advanced MRI technologies. The majority of studies used a variation on convolution neural network (CNN) architectures. Deep learning in MRI for neuro-oncology is a novel field of research; it has potential in a broad range of applications. Remaining challenges include the accessibility of large imaging datasets, the applicability across institutes/vendors and the validation and implementation of these technologies in clinical practise.

Identifiants

pubmed: 33780701
pii: S1120-1797(21)00119-8
doi: 10.1016/j.ejmp.2021.03.003
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

161-173

Informations de copyright

Copyright © 2021 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.

Auteurs

C M L Zegers (CML)

Department of Radiation Oncology (Maastro), Maastricht University Medical Center+, GROW School for Developmental Biology and Oncology, Maastricht, the Netherlands. Electronic address: karen.zegers@maastro.nl.

J Posch (J)

Department of Radiation Oncology (Maastro), Maastricht University Medical Center+, GROW School for Developmental Biology and Oncology, Maastricht, the Netherlands.

A Traverso (A)

Department of Radiation Oncology (Maastro), Maastricht University Medical Center+, GROW School for Developmental Biology and Oncology, Maastricht, the Netherlands.

D Eekers (D)

Department of Radiation Oncology (Maastro), Maastricht University Medical Center+, GROW School for Developmental Biology and Oncology, Maastricht, the Netherlands.

A A Postma (AA)

Department of Radiology & Nuclear Medicine, Maastricht University Medical Center, MHeNs School for Mental Health and Neuroscience, Maastricht, the Netherlands.

W Backes (W)

Department of Radiology & Nuclear Medicine, Maastricht University Medical Center, MHeNs School for Mental Health and Neuroscience, Maastricht, the Netherlands.

A Dekker (A)

Department of Radiation Oncology (Maastro), Maastricht University Medical Center+, GROW School for Developmental Biology and Oncology, Maastricht, the Netherlands.

W van Elmpt (W)

Department of Radiation Oncology (Maastro), Maastricht University Medical Center+, GROW School for Developmental Biology and Oncology, Maastricht, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH